Italfarmaco
Clinical trials sponsored by Italfarmaco, explained in plain language.
-
Extended hope: DMD drug GIVINOSTAT gets Long-Term safety check
Disease control Recruiting nowThis study aims to understand the long-term safety and effectiveness of the drug GIVINOSTAT in boys with Duchenne muscular dystrophy (DMD). It is open to about 206 participants, aged 6 and older, who have already taken GIVINOSTAT in a previous related study. The main goal is to m…
Phase: PHASE2, PHASE3 • Sponsor: Italfarmaco • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug trial aims to better control dangerous blood disorder
Disease control Recruiting nowThis study is testing if an investigational drug called Givinostat works better than the current standard treatment, hydroxyurea, for adults with a high-risk form of a blood cancer called polycythemia vera. The goal is to see if Givinostat can more effectively control blood count…
Phase: PHASE3 • Sponsor: Italfarmaco • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC